Validation of the Brazilian version of the Berg balance scale for patients with Parkinson's disease.

BACKGROUND: Changes in balance occur with the progression of Parkinson's disease (PD). OBJECTIVE: To validate the Brazilian version of the Berg Balance Scale (BBS) for PD patients, determining its reliability and internal consistency and correlating it with PD-specific instruments. METHOD: We evaluated 53 patients (M/F 37/16, mean age+/-SD, 62+/-7.9 years) with PD (mean+/-SD, 7.8+/-4.4 years). Unified Parkinson's Disease Rating Scale (UPDRS), Schwab and England Scale (SandE , Hoehn and Yahr Staging Scale (HY) and BBS were used to assess patients. Statistical analyses for inter-rater reliability, internal consistency and correlations among BBS, UPDRS, SandE and HY were performed. RESULTS: The mean scores+/-SD on UPDRS and BBS were, respectively, 41.6+/-17.8 and 47.2+/-8.2. The median on SandE and HY scales were 80% and 2.5, respectively. The BBS presented a high intra-class correlation coefficient (ICC=0.84) and internal consistency (Cronbrach's alpha=0.92). There was a statistically significant correlation between BBS and disease duration (r(s)= -0.520, p<0.001), UPDRS subscales II and III (r(s)= -0.467, p=0.011; r(s)= -0.374, p=0.046, respectively), stage of disease (HY; r(s)= -0.507, p<0.001) and the activities of daily living (SandE; r(s)=0.492, p<0.001). CONCLUSION: The BBS is a promising tool for the assessment of balance in PD, correlating with the stage of disease and the level of independence.

Validation of the brazilian version of the berg balance scale for patients with parkinson's disease / Validação da versão brasileira da Escala de Equilíbrio de Berg para pacientes com a doença de Parkinson

Background: Changes in balance occur with the progression of Parkinson's disease (PD). OBJECTIVE: To validate the Brazilian version of the Berg Balance Scale (BBS) for PD patients, determining its reliability and internal consistency and correlating it with PD-specific instruments. METHOD: We evaluated 53 patients (M/F 37/16, mean age±SD, 62±7.9 years) with PD (mean±SD, 7.8±4.4 years). Unified Parkinson's Disease Rating Scale (UPDRS), Schwab and England Scale (S&E), Hoehn and Yahr Staging Scale (HY) and BBS were used to assess patients. Statistical analyses for inter-rater reliability, internal consistency and correlations among BBS, UPDRS, S&E and HY were performed. RESULTS: The mean scores±SD on UPDRS and BBS were, respectively, 41.6±17.8 and 47.2±8.2. The median on S&E and HY scales were 80 percent and 2.5, respectively. The BBS presented a high intra-class correlation coefficient (ICC=0.84) and internal consistency (Cronbrach's α=0.92). There was a statistically significant correlation between BBS and disease duration (r s= -0.520, p<0.001), UPDRS subscales II and III (r s= -0.467, p=0.011; r s= -0.374, p=0.046, respectively), stage of disease (HY; r s= -0.507, p<0.001) and the activities of daily living (S&E; r s=0.492, p<0.001). CONCLUSION: The BBS is a promising tool for the assessment of balance in PD, correlating with the stage of disease and the level of independence.

Alterações de equilíbrio ocorrem com a progressão da doença de Parkinson (DP). Objetivo: Validar a versão brasileira da Escala de Equilíbrio de Berg (EEB) para pacientes com DP, determinando a confiabilidade, a consistência interna e correlacionando com instrumentos específicos da DP. MÉTODO: Foram avaliados 53 pacientes (H/M 37/16, idade média±DP, 62±7,9 anos) com DP (media±DP, 7,8±4,4 anos). Escala de Graduação Unificada da Doença de Parkinson (UPDRS), Escala de Schwab e England (S&E), Escala de Estágios de Hoehn e Yahr (HY) e EEB foram utilizadas. Análise estatística para confiabilidade entre examinadores, consistência interna e correlações entre EEB, UPDRS, S&E e HY foram realizadas. RESULTADOS: Os escores médios±DP nas escalas UPDRS e EEB foram, respectivamente, 41,6±17,8 e 47,2±8,2. A mediana nas escalas S&E e HY foram 80 por cento e 2,5. A EEB mostrou ter alto coeficiente de correlação intraclasse (ICC=0,84) e consistência interna (α de Cronbach=0,92). Houve correlação estatisticamente significativa entre EEB e a duração da doença (r s= -0,520, p<0,001), sub-escalas II e III do UPDRS (r s= -0,467, p=0,011; r s= -0,374, p=0,046, respectivamente), estágio da doença (HY; r s= -0,507, p<0,001), com as atividades da vida diária (S&E; r s= 0,492; p<0,001). CONCLUSÃO: A EEB é um instrumento promissor para avaliar o equilíbrio na DP, correlacionando-se com o estágio da doença e o nível de independência.